The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases

Receptor activator of NF-kB (RANK) pathway regulates bone remodeling and is involved in breast cancer (BC) progression. Genetic polymorphisms affecting RANK-ligand (RANKL) and osteoprotegerin (OPG) have been previously associated with BC risk and bone metastasis (BM)-free survival, respectively. In...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Ferreira, Arlindo, Alho, Irina, Vendrell, Inês, Melo, Marta, Brás, Raquel, Costa, Ana Lúcia, Sousa, Ana Rita, Mansinho, André, Abreu, Catarina, Pulido, Catarina, Macedo, Daniela, Pacheco, Teresa, Correia, Lurdes, Costa, Luis, Casimiro, Sandra
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5173066/
https://ncbi.nlm.nih.gov/pubmed/27191503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9356
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items